Brief: Respiratorius Presents Positive Results From Clinical Studies Of VAL001

Respiratorius AB (publ)

28/02/2018 07:21

Feb 28 (Reuters) - RESPIRATORIUS AB (PUBL)  RESPS.TE : 
    * RESPIRATORIUS PRESENTS POSITIVE RESULTS FROM CLINICAL 
STUDIES OF 
VAL001 
    * PUBLISHED SCIENTIFIC RESULTS FROM PHASE I STUDY SHOW A 
POTENTIAL SYNERGISTIC EFFECT WITH RITUXIMAB AS VAL001 INCREASES 
LEVELS OF SURFACE PROTEIN CD20 
 
Source text for Eikon:  ID:nWkr7PNPZR  
Further company coverage:  RESPS.TE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))